BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23427282)

  • 1. High-fructose diet downregulates long-chain acyl-CoA synthetase 3 expression in liver of hamsters via impairing LXR/RXR signaling pathway.
    Dong B; Kan CF; Singh AB; Liu J
    J Lipid Res; 2013 May; 54(5):1241-54. PubMed ID: 23427282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of serum free fatty acids and triglycerides by liver-targeted expression of long chain acyl-CoA synthetase 3.
    Wu M; Cao A; Dong B; Liu J
    Int J Mol Med; 2011 May; 27(5):655-62. PubMed ID: 21347510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of LXR increases acyl-CoA synthetase activity through direct regulation of ACSL3 in human placental trophoblast cells.
    Weedon-Fekjaer MS; Dalen KT; Solaas K; Staff AC; Duttaroy AK; Nebb HI
    J Lipid Res; 2010 Jul; 51(7):1886-96. PubMed ID: 20219900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic expression of long-chain acyl-CoA synthetase 3 is upregulated in hyperlipidemic hamsters.
    Wu M; Liu H; Chen W; Fujimoto Y; Liu J
    Lipids; 2009 Nov; 44(11):989-98. PubMed ID: 19756806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of long chain acyl-CoA synthetase 3 decreases hepatic de novo fatty acid synthesis through decreased transcriptional activity.
    Bu SY; Mashek MT; Mashek DG
    J Biol Chem; 2009 Oct; 284(44):30474-83. PubMed ID: 19737935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long chain acyl-CoA synthetase-3 is a molecular target for peroxisome proliferator-activated receptor delta in HepG2 hepatoma cells.
    Cao A; Li H; Zhou Y; Wu M; Liu J
    J Biol Chem; 2010 May; 285(22):16664-74. PubMed ID: 20308079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional activation of hepatic ACSL3 and ACSL5 by oncostatin m reduces hypertriglyceridemia through enhanced beta-oxidation.
    Zhou Y; Abidi P; Kim A; Chen W; Huang TT; Kraemer FB; Liu J
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2198-205. PubMed ID: 17761945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPARδ activation induces hepatic long-chain acyl-CoA synthetase 4 expression in vivo and in vitro.
    Kan CF; Singh AB; Dong B; Shende VR; Liu J
    Biochim Biophys Acta; 2015 May; 1851(5):577-87. PubMed ID: 25645621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SREBP2 Activation Induces Hepatic Long-chain Acyl-CoA Synthetase 1 (ACSL1) Expression in Vivo and in Vitro through a Sterol Regulatory Element (SRE) Motif of the ACSL1 C-promoter.
    Singh AB; Kan CF; Dong B; Liu J
    J Biol Chem; 2016 Mar; 291(10):5373-84. PubMed ID: 26728456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of liver x receptor/retinoid X receptor-mediated transcription contributes to the proatherogenic effects of arsenic in macrophages in vitro.
    Padovani AM; Molina MF; Mann KK
    Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1228-36. PubMed ID: 20339114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct transcriptional regulation of long-chain acyl-CoA synthetase isoforms and cytosolic thioesterase 1 in the rodent heart by fatty acids and insulin.
    Durgan DJ; Smith JK; Hotze MA; Egbejimi O; Cuthbert KD; Zaha VG; Dyck JR; Abel ED; Young ME
    Am J Physiol Heart Circ Physiol; 2006 Jun; 290(6):H2480-97. PubMed ID: 16428347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute phase response is associated with retinoid X receptor repression in rodent liver.
    Beigneux AP; Moser AH; Shigenaga JK; Grunfeld C; Feingold KR
    J Biol Chem; 2000 May; 275(21):16390-9. PubMed ID: 10747970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver X receptor regulates hepatic nuclear O-GlcNAc signaling and carbohydrate responsive element-binding protein activity.
    Bindesbøll C; Fan Q; Nørgaard RC; MacPherson L; Ruan HB; Wu J; Pedersen TÅ; Steffensen KR; Yang X; Matthews J; Mandrup S; Nebb HI; Grønning-Wang LM
    J Lipid Res; 2015 Apr; 56(4):771-85. PubMed ID: 25724563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical staining reveals differential expression of ACSL3 and ACSL4 in hepatocellular carcinoma and hepatic gastrointestinal metastases.
    Ndiaye H; Liu JY; Hall A; Minogue S; Morgan MY; Waugh MG
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32286604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide profiling of liver X receptor, retinoid X receptor, and peroxisome proliferator-activated receptor α in mouse liver reveals extensive sharing of binding sites.
    Boergesen M; Pedersen TÅ; Gross B; van Heeringen SJ; Hagenbeek D; Bindesbøll C; Caron S; Lalloyer F; Steffensen KR; Nebb HI; Gustafsson JÅ; Stunnenberg HG; Staels B; Mandrup S
    Mol Cell Biol; 2012 Feb; 32(4):852-67. PubMed ID: 22158963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ontogeny of mRNA expression and activity of long-chain acyl-CoA synthetase (ACSL) isoforms in Mus musculus heart.
    de Jong H; Neal AC; Coleman RA; Lewin TM
    Biochim Biophys Acta; 2007 Jan; 1771(1):75-82. PubMed ID: 17197235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amla prevents fructose-induced hepatic steatosis in ovariectomized rats: role of liver FXR and LXRα.
    Koshy SM; Bobby Z; Jacob SE; Ananthanarayanan PH; Sridhar MG; Paulose DT
    Climacteric; 2015 Apr; 18(2):299-310. PubMed ID: 24940994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of thyroid hormone activation via the liver X-receptor/retinoid X-receptor pathway.
    Christoffolete MA; Doleschall M; Egri P; Liposits Z; Zavacki AM; Bianco AC; Gereben B
    J Endocrinol; 2010 May; 205(2):179-86. PubMed ID: 20176747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasting-induced FGF21 is repressed by LXR activation via recruitment of an HDAC3 corepressor complex in mice.
    Archer A; Venteclef N; Mode A; Pedrelli M; Gabbi C; Clément K; Parini P; Gustafsson JÅ; Korach-André M
    Mol Endocrinol; 2012 Dec; 26(12):1980-90. PubMed ID: 23073827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skeletal muscle as a target of LXR agonist after long-term treatment: focus on lipid homeostasis.
    Archer A; Laurencikiene J; Ahmed O; Steffensen KR; Parini P; Gustafsson JÅ; Korach-André M
    Am J Physiol Endocrinol Metab; 2014 Mar; 306(5):E494-502. PubMed ID: 24368671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.